Analysts on Wall Street project that Warner Bros. Discovery (WBD) will announce quarterly loss of $0.14 per share in its forthcoming report, representing an increase of 65% year over year. Revenues are projected to reach $9.75 billion, declining 2.1% from the same quarter last year.The current level reflects an upward revision of 2.3% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projecti ...

Core Viewpoint - Analysts project that Molson Coors Brewing (TAP) will report quarterly earnings of $0.80 per share, reflecting a 15.8% decline year over year, with revenues expected to reach $2.44 billion, down 6% from the same quarter last year [1]. Earnings Projections - The consensus EPS estimate has been revised downward by 0.3% over the past 30 days, indicating a collective reassessment by analysts [2]. - Changes in earnings projections are crucial for predicting investor reactions, as empirical studies show a strong correlation between earnings estimate trends and short-term stock price movements [3]. Key Metrics Forecast - Analysts estimate 'Net Sales- EMEA&APAC' at $451.89 million, a decrease of 0.6% from the prior-year quarter [5]. - 'Net Sales- Americas' is projected at $1.96 billion, reflecting an 8.7% decline from the same quarter last year [5]. - 'Brand Volume - Consolidated' is expected to reach 16.52 million, down from 16.9 million year-over-year [5]. Brand Volumes - 'Brand Volumes - Americas' is estimated at 12.42 million, compared to 12.89 million in the same quarter last year [6]. - 'Brand Volumes - EMEA&APAC' is projected at 3.82 million, down from 4.01 million in the same quarter last year [6]. Operating Income - The consensus for 'Operating income(loss)- Americas' is $271.60 million, a decrease from $320.60 million reported in the same quarter last year [7]. - Molson Coors shares have declined by 5.9% in the past month, contrasting with a 0.4% increase in the Zacks S&P 500 composite [7].

Core Viewpoint - Nutrien (NTR) is expected to report a quarterly earnings per share (EPS) of $0.33, reflecting a 28.3% decline year-over-year, with revenues forecasted at $5.32 billion, a decrease of 1.2% from the previous year [1]. Earnings Estimates - The consensus EPS estimate has been revised 0.5% higher in the last 30 days, indicating a collective reevaluation by analysts [2]. - Revisions to earnings projections are crucial for predicting investor behavior and stock performance [3]. Sales and Revenue Projections - Analysts predict 'Sales- Retail Total' to reach $3.49 billion, marking a 5.6% increase from the year-ago quarter [4]. - 'Sales- Nitrogen' is expected to be $972.08 million, down 5.4% year-over-year [5]. - 'Sales- Potash' is forecasted at $783.90 million, indicating a 15.4% decline from the prior year [5]. - 'Sales- Phosphate' is estimated at $435.19 million, reflecting a 12.8% decrease from the previous year [5]. Volume and Pricing Estimates - 'Tonnes Sold - Potash - Total' is projected at 3,255.30 KTon, down from 3,413 KTon year-over-year [6]. - 'Tonnes Sold - Nitrogen' is expected to be 2,473.23 KTon, slightly down from 2,507 KTon [6]. - The average selling price for 'Phosphate - Industrial and feed' is estimated at $777.80 per tonne, down from $848 per tonne in the same quarter last year [7]. - The average selling price for 'Phosphate - Total' is projected at $614.19 per tonne, compared to $689 per tonne a year ago [7]. - 'Average Selling Price per Tonne - Nitrogen - Solutions, nitrates and sulphates' is expected to be $220.56 per tonne, down from $226 per tonne [8]. - 'Average Selling Price per Tonne - Nitrogen - Urea and ESN' is estimated at $410.89 per tonne, compared to $432 per tonne last year [8]. - 'Average Selling Price per Tonne - Nitrogen - Ammonia' is forecasted at $417.19 per tonne, slightly up from $403 per tonne [9]. - 'Tonnes Sold - Phosphate' is expected to be 569.00 KTon, down from 620 KTon in the same quarter last year [9]. Stock Performance - Over the past month, Nutrien shares have returned +11.9%, while the Zacks S&P 500 composite has seen a -0.5% change [9]. - Nutrien currently holds a Zacks Rank 3 (Hold), suggesting its performance may align with the overall market in the near future [10].

Core Viewpoint - AMC Entertainment is expected to report a quarterly loss of $0.56 per share, reflecting a year-over-year increase of 28.2%, with revenues projected at $874.53 million, down 8.1% from the previous year [1]. Group 1: Earnings Projections - Over the last 30 days, the consensus EPS estimate for AMC has been revised upward by 15.7%, indicating a collective reassessment by analysts [2]. - Changes in earnings projections are crucial for predicting investor reactions, as empirical studies show a strong correlation between earnings estimate trends and short-term stock price movements [3]. Group 2: Revenue Estimates - Analysts estimate 'Revenues- Food and beverage' to reach $294.23 million, representing a decline of 8.4% year-over-year [5]. - The 'Revenues- Other theatre' is projected at $91.87 million, indicating a year-over-year decrease of 7.9% [5]. - 'Revenues- Admissions' are expected to be $488.40 million, also suggesting a year-over-year change of -7.9% [5]. Group 3: Stock Performance - AMC Entertainment shares have increased by 0.4% over the past month, contrasting with a -0.5% change in the Zacks S&P 500 composite [6]. - With a Zacks Rank of 3 (Hold), AMC is anticipated to closely follow overall market performance in the near term [6].

Core Viewpoint - Cencora (COR) is expected to report quarterly earnings of $4.08 per share, reflecting a 7.4% increase year-over-year, with revenues projected at $74.82 billion, indicating a 9.4% growth compared to the previous year [1]. Earnings Projections - The consensus EPS estimate has been revised upward by 0.2% in the last 30 days, showcasing analysts' reassessment of their initial projections [2]. - Changes in earnings projections are crucial for predicting investor reactions, as empirical studies show a strong correlation between earnings estimate trends and short-term stock price movements [3]. Revenue Estimates - Analysts estimate 'Revenue- Total International Healthcare Solutions' at $7.36 billion, a year-over-year increase of 3.3% [5]. - The consensus for 'Revenue- Total U.S. Healthcare Solutions' is $67.56 billion, reflecting a 10.2% increase from the same quarter last year [5]. - 'Revenue- International Healthcare Solutions- Alliance Healthcare' is projected to reach $5.98 billion, indicating a 3.9% year-over-year change [6]. - 'Revenue- U.S. Healthcare Solutions- Animal Health' is expected to be $1.49 billion, suggesting a 14.1% increase year-over-year [6]. - 'Revenue- U.S. Healthcare Solutions- Human Health' is forecasted at $65.56 billion, reflecting a 9.3% year-over-year growth [6]. - 'Revenue- International Healthcare Solutions- Other Healthcare Solutions' is estimated at $1.42 billion, indicating a 3.8% increase from the previous year [7]. Operating Income Estimates - Analysts project 'Operating income- Non-GAAP- International Healthcare Solutions' to be $182.43 million, down from $192.72 million reported in the same quarter last year [7]. - 'Operating income- Non-GAAP- U.S. Healthcare Solutions' is expected to reach $926.36 million, compared to $841.06 million from the previous year [8]. Stock Performance - Over the past month, Cencora shares have returned +0.4%, outperforming the Zacks S&P 500 composite, which recorded a -0.5% change [8].

Core Viewpoint - Estee Lauder is expected to report a significant decline in quarterly earnings and revenues, reflecting a downward revision in analysts' projections over the past month [1][2]. Financial Performance - The anticipated earnings per share (EPS) for Estee Lauder is $0.29, representing a 70.1% decline year over year [1]. - Analysts forecast revenues of $3.51 billion, indicating an 11% decrease compared to the previous year [1]. - The consensus EPS estimate has been revised down by 8.5% over the last 30 days [1]. Sales Projections by Category - Net sales for Skin Care are projected to reach $1.87 billion, down 9.3% year over year [4]. - Makeup net sales are expected to be $1.07 billion, reflecting a 6% decrease from the prior year [4]. - Other net sales are estimated at -$38.46 million, indicating a drastic decline of 247.9% year over year [4]. - Hair Care net sales are forecasted at $134.79 million, down 5.7% from the previous year [5]. - Fragrance net sales are projected to be $574.19 million, showing a slight decrease of 0.1% [5]. - Net sales in The Americas are expected to reach $1.08 billion, down 3.1% year over year [5]. - Sales in Europe, the Middle East & Africa are estimated at $1.40 billion, reflecting a 15.1% decline [6]. - Asia/Pacific net sales are projected at $1.02 billion, indicating a 13.3% decrease [6]. Operating Income Projections - Operating income for Skin Care is expected to be $354.08 million, down from $468 million year over year [6]. - Operating income for Other is projected at -$220.82 million, compared to a positive $11 million last year [7]. - Makeup operating income is estimated at $53.44 million, down from $66 million [7]. - Fragrance operating income is expected to be $17.18 million, compared to $29 million in the previous year [8]. Stock Performance - Estee Lauder shares have decreased by 12.2% over the past month, contrasting with the Zacks S&P 500 composite's decline of only 0.2% [8].

Core Viewpoint - Analysts expect Williams Companies, Inc. (WMB) to report quarterly earnings of $0.57 per share, reflecting a year-over-year decline of 3.4%, while revenues are projected to be $3.14 billion, an increase of 13.4% from the previous year [1] Earnings Projections - The consensus EPS estimate has been revised 4.6% lower over the last 30 days, indicating a reevaluation of initial estimates by analysts [1][2] Key Metrics Estimates - Analysts predict 'Northeast G&P - Gathering volumes' at 4.31 Bcf/D, slightly down from 4.33 Bcf/D a year ago [4] - 'West - NGL equity sales' are expected to reach 6 million barrels of oil per day, unchanged from the previous year [4] - 'West - Gathering volumes' are forecasted at 5.71 Bcf/D, down from 5.75 Bcf/D in the same quarter last year [5] - 'Adjusted EBITDA- Other' is projected to be $108.41 million, up from $74 million year-over-year [5] - 'Adjusted EBITDA- Northeast G&P' is estimated at $495.34 million, down from $504 million a year ago [5] - 'Adjusted EBITDA- Transmission and Gulf of Mexico' is expected to reach $897.66 million, compared to $839 million in the same quarter last year [6] - 'Adjusted EBITDA- West' is projected at $366.14 million, up from $328 million year-over-year [6] - 'Adjusted EBITDA- Gas & NGL Marketing Services' is expected to be $119.41 million, down from $189 million a year ago [7] - 'Modified EBITDA- Northeast G&P' is estimated at $491.69 million, slightly down from $504 million in the previous year [7] - 'Modified EBITDA- Transmission and Gulf of Mexico' is projected at $907.81 million, up from $829 million year-over-year [8] - 'Modified EBITDA- West' is expected to be $374.29 million, compared to $327 million in the same quarter last year [8] Stock Performance - Over the past month, Williams Companies shares have recorded a return of -1.5%, compared to the Zacks S&P 500 composite's -0.2% change, indicating a performance that aligns with the overall market [8]

Wall Street analysts expect CBOE Global (CBOE) to post quarterly earnings of $2.36 per share in its upcoming report, which indicates a year-over-year increase of 9.8%. Revenues are expected to be $556.64 million, up 10.9% from the year-ago quarter.Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted upward by 6.5% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.Before a company reveals its e ...

Core Viewpoint - Mettler-Toledo (MTD) is expected to report a quarterly earnings per share (EPS) of $7.90, reflecting an 11.1% year-over-year decline, with revenues projected at $875.01 million, down 5.5% from the previous year [1]. Earnings Estimates - The consensus EPS estimate has remained unchanged over the past 30 days, indicating that analysts have not revised their projections during this period [2]. - Revisions to earnings projections are crucial for predicting investor behavior and are linked to short-term stock price performance [3]. Revenue and Sales Projections - Analysts estimate 'Net sales- Products' at $670.72 million, representing a 4.3% decline year-over-year [5]. - 'Net sales- Service (Point in Time+Over Time)' is projected to be $208.59 million, indicating a 7.3% decrease from the year-ago quarter [5]. - 'Net sales- Retail' is expected to reach $42.69 million, reflecting a 13% year-over-year decline [5]. - 'Net sales- Industrial' is forecasted at $332.70 million, showing a 5.4% decrease from the prior-year quarter [6]. - 'Net sales- Laboratory' is anticipated to be $495.28 million, indicating a 5.7% decline from the previous year [6]. Stock Performance - Mettler-Toledo shares have experienced a return of -7.9% over the past month, compared to a -0.2% change in the Zacks S&P 500 composite [6]. - The company holds a Zacks Rank of 3 (Hold), suggesting it is expected to perform in line with the overall market in the near future [6].

The upcoming report from Monolithic Power (MPWR) is expected to reveal quarterly earnings of $4 per share, indicating an increase of 42.4% compared to the year-ago period. Analysts forecast revenues of $632.18 million, representing an increase of 38.1% year over year.Over the last 30 days, there has been no revision in the consensus EPS estimate for the quarter. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.Before a company reve ...